{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:42:36Z","timestamp":1779223356470,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","award":["CF_61004"],"award-info":[{"award-number":["CF_61004"]}],"id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40121-020-00331-4","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T18:04:00Z","timestamp":1598637840000},"page":"807-821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genetic Risk Surveillance for Invasive Aspergillosis in Hematology Patients: A Prospective Observational Study"],"prefix":"10.1007","volume":"9","author":[{"given":"Tananun","family":"Tanpaibule","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natini","family":"Jinawath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruchalean","family":"Taweewongsounton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pimjai","family":"Niparuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0966-2708","authenticated-orcid":false,"given":"Porpon","family":"Rotjanapan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"331_CR1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","volume":"70","author":"C Kosmidis","year":"2015","unstructured":"Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015;70:270\u20137.","journal-title":"Thorax"},{"key":"331_CR2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"DP Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50:1091\u2013100.","journal-title":"Clin Infect Dis"},{"key":"331_CR3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","volume":"95","author":"L Pagano","year":"2010","unstructured":"Pagano L, Caira M, Candoni A, et al. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica. 2010;95:644\u201350.","journal-title":"Haematologica"},{"key":"331_CR4","first-page":"1068","volume":"91","author":"L Pagano","year":"2006","unstructured":"Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006;91:1068\u201375.","journal-title":"Haematologica"},{"key":"331_CR5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MOH.0000000000000086","volume":"21","author":"C Girmenia","year":"2014","unstructured":"Girmenia C, Ferretti A, Barberi W. Epidemiology and risk factors for invasive fungal diseases in hematopoietic stem cell transplantation. Curr Opin Hematol. 2014;21:459\u201365.","journal-title":"Curr Opin Hematol"},{"key":"331_CR6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diagmicrobio.2012.06.012","volume":"73","author":"N Azie","year":"2012","unstructured":"Azie N, Neofytos D, Pfaller M, Meier-Kriesche HU, Quan SP, Horn D. The PATH (Prospective Antifungal Therapy) Alliance\u00ae registry and invasive fungal infections: update 2012. Diagn Microbiol Infect Dis. 2012;73:293\u2013300.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"331_CR7","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1086\/591531","volume":"47","author":"L Slobbe","year":"2008","unstructured":"Slobbe L, Polinder S, Doorduijn JK, et al. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study. Clin Infect Dis. 2008;47:1507\u201312.","journal-title":"Clin Infect Dis"},{"key":"331_CR8","first-page":"895","volume":"90","author":"S Kiertiburanakul","year":"2007","unstructured":"Kiertiburanakul S, Thibbadee C, Santanirand P. Invasive aspergillosis in a tertiary-care hospital in Thailand. J Med Assoc Thail. 2007;90:895\u2013902.","journal-title":"J Med Assoc Thail"},{"key":"331_CR9","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/AAC.01423-10","volume":"55","author":"MR Ananda-Rajah","year":"2011","unstructured":"Ananda-Rajah MR, Cheng A, Morrissey CO, et al. Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach. Antimicrob Agents Chemother. 2011;55:1953\u201360.","journal-title":"Antimicrob Agents Chemother"},{"key":"331_CR10","doi-asserted-by":"crossref","first-page":"e1003743","DOI":"10.1371\/journal.ppat.1003743","volume":"9","author":"KJ Kwon-Chung","year":"2013","unstructured":"Kwon-Chung KJ, Sugui JA. Aspergillus fumigatus\u2013what makes the species a ubiquitous human fungal pathogen? PLoS Pathog. 2013;9:e1003743.","journal-title":"PLoS Pathog"},{"key":"331_CR11","doi-asserted-by":"crossref","first-page":"e75531","DOI":"10.1371\/journal.pone.0075531","volume":"8","author":"M Stanzani","year":"2013","unstructured":"Stanzani M, Lewis RE, Fiacchini M, et al. A risk prediction score for invasive mold disease in patients with hematological malignancies. PLoS One. 2013;8:e75531.","journal-title":"PLoS One"},{"key":"331_CR12","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3109\/13693786.2010.505204","volume":"49","author":"JW Baddley","year":"2011","unstructured":"Baddley JW. Clinical risk factors for invasive aspergillosis. Med Mycol. 2011;49:S7\u2013S12.","journal-title":"Med Mycol"},{"key":"331_CR13","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dkq437","volume":"66","author":"L Pagano","year":"2011","unstructured":"Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother. 2011;66:i5\u2013i14.","journal-title":"J Antimicrob Chemother"},{"key":"331_CR14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1749-6632.2012.06829.x","volume":"1272","author":"R Herbrecht","year":"2012","unstructured":"Herbrecht R, Bories P, Moulin JC, Ledoux MP, Letscher-Bru V. Risk stratification for invasive aspergillosis in immunocompromised patients. Ann NY Acad Sci. 2012;1272:23\u201330.","journal-title":"Ann NY Acad Sci"},{"key":"331_CR15","doi-asserted-by":"crossref","first-page":"e1003434","DOI":"10.1371\/journal.ppat.1003434","volume":"9","author":"C Cunha","year":"2013","unstructured":"Cunha C, Aversa F, Romani L, Carvalho A. Human genetic susceptibility to invasive aspergillosis. PLoS Pathog. 2013;9:e1003434.","journal-title":"PLoS Pathog"},{"key":"331_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00281-014-0468-y","volume":"37","author":"A Wojtowicz","year":"2015","unstructured":"Wojtowicz A, Bochud PY. Host genetics of invasive Aspergillus and Candida infections. Semin Immunopathol. 2015;37:173\u201386.","journal-title":"Semin Immunopathol"},{"key":"331_CR17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ni.3045","volume":"16","author":"JA Whitsett","year":"2014","unstructured":"Whitsett JA, Alenghat T. Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat Immunol. 2014;16:27\u201335.","journal-title":"Nat Immunol"},{"key":"331_CR18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/cid\/ciu337","volume":"59","author":"JF Camargo","year":"2014","unstructured":"Camargo JF, Husain S. Immune correlates of protection in human invasive aspergillosis. Clin Infect Dis. 2014;59:569\u201377.","journal-title":"Clin Infect Dis"},{"key":"331_CR19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nri2939","volume":"11","author":"L Romani","year":"2011","unstructured":"Romani L. Immunity to fungal infections. Nat Rev Immunol. 2011;11:275\u201388.","journal-title":"Nat Rev Immunol"},{"key":"331_CR20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/myc.12052","volume":"56","author":"C Lass-Florl","year":"2013","unstructured":"Lass-Florl C, Roilides E, Loffler J, Wilflingseder D, Romani L. Minireview: host defence in invasive aspergillosis. Mycoses. 2013;56:403\u201313.","journal-title":"Mycoses"},{"key":"331_CR21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/CMR.00014-09","volume":"22","author":"SJ Park","year":"2009","unstructured":"Park SJ, Mehrad B. Innate immunity to Aspergillus species. Clin Microbiol Rev. 2009;22:535\u201351.","journal-title":"Clin Microbiol Rev"},{"key":"331_CR22","first-page":"156","volume":"3","author":"A Carvalho","year":"2012","unstructured":"Carvalho A, Cunha C, Bozza S, et al. Immunity and tolerance to fungi in hematopoietic transplantation: principles and perspectives. Front Immunol. 2012;3:156.","journal-title":"Front Immunol"},{"key":"331_CR23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3389\/fmicb.2015.00411","volume":"6","author":"A Oliveira-Coelho","year":"2015","unstructured":"Oliveira-Coelho A, Rodrigues F, Campos A Jr, Lacerda JF, Carvalho A, Cunha C. Paving the way for predictive diagnostics and personalized treatment of invasive aspergillosis. Front Microbiol. 2015;6:411.","journal-title":"Front Microbiol"},{"key":"331_CR24","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.bmt.1705181","volume":"36","author":"KW Seo","year":"2005","unstructured":"Seo KW, Kim DH, Sohn SK, et al. Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation. Bone Marrow Transpl. 2005;36:1089\u201395.","journal-title":"Bone Marrow Transpl"},{"key":"331_CR25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.imlet.2007.01.005","volume":"109","author":"J Sainz","year":"2007","unstructured":"Sainz J, Hassan L, Perez E, et al. Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis. Immunol Lett. 2007;109:76\u201382.","journal-title":"Immunol Lett"},{"key":"331_CR26","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1056\/NEJMoa0802629","volume":"359","author":"PY Bochud","year":"2008","unstructured":"Bochud PY, Chien JW, Marr KA, et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med. 2008;359:1766\u201377.","journal-title":"N Engl J Med"},{"key":"331_CR27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1182\/blood-2007-05-090928","volume":"111","author":"M Mezger","year":"2008","unstructured":"Mezger M, Steffens M, Beyer M, et al. Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and influence CXCL10 expression in monocyte-derived dendritic cells. Blood. 2008;111:534\u20136.","journal-title":"Blood"},{"key":"331_CR28","doi-asserted-by":"crossref","first-page":"e1000101","DOI":"10.1371\/journal.pgen.1000101","volume":"4","author":"AK Zaas","year":"2008","unstructured":"Zaas AK, Liao G, Chien JW, et al. Plasminogen alleles influence susceptibility to invasive aspergillosis. PLoS Genet. 2008;4:e1000101.","journal-title":"PLoS Genet"},{"key":"331_CR29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/039463201002300205","volume":"23","author":"J Sainz","year":"2010","unstructured":"Sainz J, Salas-Alvarado I, Lopez-Fernandez E, et al. TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis. Int J Immunopathol Pharmacol. 2010;23:423\u201336.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"331_CR30","doi-asserted-by":"crossref","first-page":"e27962","DOI":"10.1371\/journal.pone.0027962","volume":"6","author":"C Cunha","year":"2011","unstructured":"Cunha C, Giovannini G, Pierini A, et al. Genetically-determined hyperfunction of the S100B\/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients. PLoS One. 2011;6:e27962.","journal-title":"PLoS One"},{"key":"331_CR31","doi-asserted-by":"crossref","first-page":"e18403","DOI":"10.1371\/journal.pone.0018403","volume":"6","author":"MG de Boer","year":"2011","unstructured":"de Boer MG, Jolink H, Halkes CJ, et al. Influence of polymorphisms in innate immunity genes on susceptibility to invasive aspergillosis after stem cell transplantation. PLoS One. 2011;6:e18403.","journal-title":"PLoS One"},{"key":"331_CR32","doi-asserted-by":"crossref","first-page":"e32273","DOI":"10.1371\/journal.pone.0032273","volume":"7","author":"J Sainz","year":"2012","unstructured":"Sainz J, Lupianez CB, Segura-Catena J, et al. Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary aspergillosis infection. PLoS One. 2012;7:e32273.","journal-title":"PLoS One"},{"key":"331_CR33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/tid.12115","volume":"15","author":"M Koldehoff","year":"2013","unstructured":"Koldehoff M, Beelen DW, Elmaagacli AH. Increased susceptibility for aspergillosis and post-transplant immune deficiency in patients with gene variants of TLR4 after stem cell transplantation. Transpl Infect Dis. 2013;15:533\u20139.","journal-title":"Transpl Infect Dis"},{"key":"331_CR34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1211161","volume":"370","author":"C Cunha","year":"2014","unstructured":"Cunha C, Aversa F, Lacerda JF, et al. Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. N Engl J Med. 2014;370:421\u201332.","journal-title":"N Engl J Med"},{"key":"331_CR35","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/IAI.01359-15","volume":"84","author":"CB Lupianez","year":"2015","unstructured":"Lupianez CB, Canet LM, Carvalho A, et al. Polymorphisms in host immunity-modulating genes and risk of invasive aspergillosis: results from the AspBIOmics consortium. Infect Immun. 2015;84:643\u201357.","journal-title":"Infect Immun"},{"key":"331_CR36","doi-asserted-by":"crossref","first-page":"e0150632","DOI":"10.1371\/journal.pone.0150632","volume":"11","author":"M Fischer","year":"2016","unstructured":"Fischer M, Spies-Weisshart B, Schrenk K, et al. Polymorphisms of dectin-1 and TLR2 predispose to invasive fungal disease in patients with acute myeloid leukemia. PLoS One. 2016;11:e0150632.","journal-title":"PLoS One"},{"key":"331_CR37","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813\u201321.","journal-title":"Clin Infect Dis"},{"key":"331_CR38","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1182\/blood-2006-03-008706","volume":"108","author":"R Martino","year":"2006","unstructured":"Martino R, Parody R, Fukuda T, et al. Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: a retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood. 2006;108:2928\u201336.","journal-title":"Blood"},{"key":"331_CR39","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2141.2004.05140.x","volume":"126","author":"J Maertens","year":"2004","unstructured":"Maertens J, Theunissen K, Verbeken E, et al. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol. 2004;126:852\u201360.","journal-title":"Br J Haematol"},{"key":"331_CR40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/jof2030022","volume":"2","author":"F Lamoth","year":"2016","unstructured":"Lamoth F. Galactomannan and 1,3-beta-d-glucan testing for the diagnosis of invasive aspergillosis. J Fungi (Basel). 2016;2:22.","journal-title":"J Fungi (Basel)"},{"key":"331_CR41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1128\/JCM.44.2.389-394.2006","volume":"44","author":"A Aubry","year":"2006","unstructured":"Aubry A, Porcher R, Bottero J, et al. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders. J Clin Microbiol. 2006;44:389\u201394.","journal-title":"J Clin Microbiol"},{"key":"331_CR42","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1128\/JCM.42.11.5362-5363.2004","volume":"42","author":"D Mattei","year":"2004","unstructured":"Mattei D, Rapezzi D, Mordini N, et al. False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment. J Clin Microbiol. 2004;42:5362\u20133.","journal-title":"J Clin Microbiol"},{"key":"331_CR43","doi-asserted-by":"crossref","first-page":"459405","DOI":"10.1155\/2013\/459405","volume":"2013","author":"RC Barton","year":"2013","unstructured":"Barton RC. Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome. Scientifica. 2013;2013:459405.","journal-title":"Scientifica"},{"key":"331_CR44","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.leu.2403674","volume":"19","author":"K Muhlemann","year":"2005","unstructured":"Muhlemann K, Wenger C, Zenhausern R, Tauber MG. Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies. Leukemia. 2005;19:545\u201350.","journal-title":"Leukemia"},{"key":"331_CR45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/tid.12328","volume":"17","author":"A Atalla","year":"2015","unstructured":"Atalla A, Garnica M, Maiolino A, Nucci M. Risk factors for invasive mold diseases in allogeneic hematopoietic cell transplant recipients. Transpl Infect Dis. 2015;17:7\u201313.","journal-title":"Transpl Infect Dis"},{"key":"331_CR46","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/mmy\/myx029","volume":"56","author":"P Rotjanapan","year":"2018","unstructured":"Rotjanapan P, Chen YC, Chakrabarti A, et al. Epidemiology and clinical characteristics of invasive mould infections: a multicenter, retrospective analysis in five Asian countries. Med Mycol. 2018;56:186\u201396.","journal-title":"Med Mycol"},{"key":"331_CR47","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/CMR.12.2.310","volume":"12","author":"JP Latge","year":"1999","unstructured":"Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999;12:310\u201350.","journal-title":"Clin Microbiol Rev"},{"key":"331_CR48","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1086\/591969","volume":"47","author":"C Garcia-Vidal","year":"2008","unstructured":"Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis. 2008;47:1041\u201350.","journal-title":"Clin Infect Dis"},{"key":"331_CR49","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3390\/ijms20061373","volume":"20","author":"F Marchesi","year":"2019","unstructured":"Marchesi F, Pimpinelli F, Di Domenico EG, et al. Association between CMV and invasive fungal infections after autologous stem cell transplant in lymphoproliferative malignancies: opportunistic partnership or cause-effect relationship? Int J Mol Sci. 2019;20:1373.","journal-title":"Int J Mol Sci"},{"key":"331_CR50","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1128\/JCM.06423-11","volume":"50","author":"J D'Haese","year":"2012","unstructured":"D'Haese J, Theunissen K, Vermeulen E, et al. Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity. J Clin Microbiol. 2012;50:1258\u201363.","journal-title":"J Clin Microbiol"},{"key":"331_CR51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cyto.2011.08.031","volume":"58","author":"S Vautier","year":"2012","unstructured":"Vautier S, MacCallum DM, Brown GD. C-type lectin receptors and cytokines in fungal immunity. Cytokine. 2012;58:89\u201399.","journal-title":"Cytokine"},{"key":"331_CR52","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1093\/mmy\/myy057","volume":"57","author":"C Cunha","year":"2019","unstructured":"Cunha C, Carvalho A. Genetic defects in fungal recognition and susceptibility to invasive pulmonary aspergillosis. Med Mycol. 2019;57:S211\u2013S218218.","journal-title":"Med Mycol"},{"key":"331_CR53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.hemonc.2017.05.013","volume":"10","author":"AS Omrani","year":"2017","unstructured":"Omrani AS, Almaghrabi RS. Complications of hematopoietic stem transplantation: fungal infections. Hematol Oncol Stem Cell Ther. 2017;10:239\u201344.","journal-title":"Hematol Oncol Stem Cell Ther"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-020-00331-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-020-00331-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-020-00331-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T13:17:43Z","timestamp":1696598263000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-020-00331-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["331"],"URL":"https:\/\/doi.org\/10.1007\/s40121-020-00331-4","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]},"assertion":[{"value":"10 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}